Informace o publikaci

Role of histamine receptors in the effects of histamine on the production of reactive oxygen species by whole blood phagocytes

Autoři

VAŠÍČEK Ondřej LOJEK Antonín JANČINOVÁ Viera NOSAL Radomír ČÍŽ Milan

Rok publikování 2014
Druh Článek v odborném periodiku
Časopis / Zdroj Life Sciences
Citace
www http://www.sciencedirect.com/science/article/pii/S0024320514002203
Doi http://dx.doi.org/10.1016/j.lfs.2014.01.082
Klíčová slova Histamine; Histamine receptors; H2R; H4R; Reactive oxygen species; Phagocytes
Popis Aims The diverse physiological functions of histamine are mediated through distinct histamine receptors. In this study we investigated the role of H2R and H4R in the effects of histamine on the production of reactive oxygen species by phagocytes in whole blood. Main methods Changes in reactive oxygen species (ROS) production by whole blood phagocytes after treatment with histamine, H4R agonists (4-methylhistamine, VUF8430), H2R agonist (dimaprit) and their combinations with H4R antagonist (JNJ10191584) and H2R antagonist (ranitidine) were determined using the chemiluminescence (CL) assay. To exclude the direct scavenging effects of the studied compounds on the CL response, the antioxidant properties of all compounds were measured using several methods (TRAP, ORAC, and luminol HRP H2O2 based CL). Key findings Histamine, 4methylhistamine, VUF8430 and dimaprit inhibited the spontaneous and OZP activated whole blood CL in a dose dependent manner. On the other hand, only VUF8430 was able to inhibit PMA activated whole blood CL. Ranitidine, but not JNJ10191584, completely reduced the effects of histamine, 4methylhistamine and dimaprit. The direct scavenging ability of tested compounds was negligible. Significance Our results demonstrate that the inhibitory effects of histamine on ROS production in whole blood phagocytes were caused by H2R. Our results also suggest that H4R agonists in concentrations higher than 1uM may also influence ROS production via binding to H2R.

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info